Clinical Trials Browser

Phase 4 × Not yet recruiting × relmacabtagene autoleucel × Clear all

NCT05814848 2023-06-15

A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma

Phase 4 Not yet recruiting

Recurrence, Lymphoma, B-Cell